Koya Medical names Thomas Maldonado as chief medical officer

937
Maldonado
Thomas Maldonado

Koya Medical recently announced the appointment of Thomas Maldonado (New York University Medical Center, New York, USA) as chief medical officer and a member of the company’s clinical advisory board.

A press release notes that Maldonado has been one of New York City’s top vascular surgeons in one of the nation’s premier academic medical centres for over two decades. He is regularly featured as Top Doctor by Castle Connolly and has served as president of numerous national and regional vascular societies. Maldonado is also a prolific researcher and academician with over 150 publications in the field of vascular surgery and serves as editor-in-chief for the journal, Vascular and Endovascular Surgery.

Maldonado states that he is “honoured to serve as chief medical officer for Koya Medical and looks forward to continuing to advance the Dayspring to help even more people with lymphoedema and venous diseases maintain mobility while receiving effective compression treatment.”

According to Koya Medical, Dayspring is the first and only non-pneumatic active dynamic compression treatment designed for patient mobility and cleared by the US Food and Drug Administration (FDA) to treat lymphoedema and chronic venous conditions.

The company adds that it is the first wearable and mobility-enabled active compression system designed with real life in mind. It is the first compression treatment option designed to enable movement, mobility, and personalised care that is unavailable with existing traditional pneumatic compression. The Dayspring system includes a low-profile active garment made of soft, breathable mesh using Koya’s proprietary Flexframe technology; a smart, rechargeable, hand-held controller that can be worn on a lanyard; and a mobile app that allows users or their clinicians to track therapy and customise treatment options.

Dayspring is FDA 510(k) cleared to treat lymphoedema, primary lymphoedema, post mastectomy oedema, oedema following trauma and sports injuries, post immobilisation oedema, venous insufficiency, venous stasis ulcers, or arterial and diabetic leg ulcers, lipoedema and phlebolymphoedema and other similar conditions that impact lymphatic flow in the upper and lower extremities. Dayspring is also indicated to reduce wound healing time and treatment and assist in healing stasis dermatitis.


LEAVE A REPLY

Please enter your comment!
Please enter your name here